跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 254 条关于
“IBI310”
全部
254
临床试验
212
药物
19
机构
0
资讯
23
去年
Innovent Highlights IBI343 Data in Pancreatic Cancer at ESMO Asia 2024
去年
Pipeline Analysis Reveals 75+ Drug Candidates in Development for Advanced Cervical Cancer Treatment
去年
Innovent Highlights Promising Clinical Data on Novel Oncology Molecules at ESMO Asia 2024
去年
Optimizing Neoadjuvant Immunotherapy Strategies in Colorectal Cancer
2年前
IBI363 Receives FDA Designation, Advancing Treatment for Unspecified Condition
去年
Innovent's IBI343 Shows Promise in Advanced Pancreatic Cancer Trial
2年前
FDA Grants Fast Track Designation to IBI363 for Advanced Melanoma
2年前
Innovent and SanegeneBio Initiate Phase 1 Trial of IBI3016 for Hypertension
去年
Innovent's IBI343 Receives Breakthrough Therapy Designation in China for Advanced Pancreatic Cancer
去年
IBI354 Demonstrates Promising Efficacy and Tolerability in HER2-Positive and HER2-Low Breast Cancer
第 1 页,共 3 页
上一页
下一页